Clinical Trials Browser

Phase 2/3 × INDUSTRY × Irinotecan × Clear all

NCT05427383 2023-12-19

KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy

Phase 2/3 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT01550055 2019-04-10

CRC009

Phase 2/3 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00284258 2012-11-02

Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer

Phase 2/3 Completed

Gastrointestinal

Colorectal Neoplasms